Leadership changes at Mallinckrodt

|About: Mallinckrodt PLC (MNK)|By:, SA News Editor

Mallinckrodt (NYSE:MNK) announces the following executive changes pursuant to the Questcor (NASDAQ:QCOR) acquisition:

SVP and Chief Strategy Officer Gary Phillips, M.D. appointed as SVP and President of Autoimmune and Rare Disease business (includes the commercial organization supporting H.P. Acthar Gel).

Questcor SVP and Chief Compliance Officer Ray Furey appointed as SVP and Chief Compliance Officer at Mallinckrodt.

Both executives will report to CEO Mark Trudeau. A search is underway for a Chief Strategy Officer.